Cite
Baird AM, Easty D, Jarzabek M, et al. When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?. Front Endocrinol (Lausanne). 2019;10:89doi: 10.3389/fendo.2019.00089.
Baird, A. M., Easty, D., Jarzabek, M., Shiels, L., Soltermann, A., Klebe, S., Raeppel, S., MacDonagh, L., Wu, C., Griggs, K., Kirschner, M. B., Stanfill, B., Nonaka, D., Goparaju, C. M., Murer, B., Fennell, D. A., O'Donnell, D. M., Barr, M. P., Mutti, L., Reid, G., Finn, S., Cuffe, S., Pass, H. I., Opitz, I., Byrne, A. T., O'Byrne, K. J., & Gray, S. G. (2019). When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?. Frontiers in endocrinology, 1089. https://doi.org/10.3389/fendo.2019.00089
Baird, Anne-Marie, et al. "When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?." Frontiers in endocrinology vol. 10 (2019): 89. doi: https://doi.org/10.3389/fendo.2019.00089
Baird AM, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, Raeppel S, MacDonagh L, Wu C, Griggs K, Kirschner MB, Stanfill B, Nonaka D, Goparaju CM, Murer B, Fennell DA, O'Donnell DM, Barr MP, Mutti L, Reid G, Finn S, Cuffe S, Pass HI, Opitz I, Byrne AT, O'Byrne KJ, Gray SG. When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?. Front Endocrinol (Lausanne). 2019 Feb 26;10:89. doi: 10.3389/fendo.2019.00089. eCollection 2019. PMID: 30863365; PMCID: PMC6399142.
Copy
Download .nbib